DDDD - ETF AI Analysis
Top Page
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD)
Rating:74Outperform
Price Target:―
Positive Factors
Strong Leading Holding
Texas Instruments has shown very strong recent performance, which has helped support the ETF’s overall returns.
Defensive Sector Tilt
Significant exposure to health care and consumer defensive companies can provide some stability during market downturns.
Broad Industry Mix
Holdings spread across technology, energy, communication services, industrials, consumer sectors, and financials help reduce reliance on any single industry.
Negative Factors
High Expense Ratio
The ETF charges relatively high fees, which can eat into long-term returns compared with lower-cost funds.
Heavy U.S. Concentration
With the vast majority of assets in U.S. stocks, the fund offers limited diversification across global markets.
Mixed Top-Holding Performance
While several major holdings have been strong, at least one key stock has been weak recently, which can drag on the fund’s overall results.
DDDD vs. SPDR S&P 500 ETF (SPY)
AUM5.58M
RegionNorth America
Expense Ratio1.01%
Beta0.08
IssuerYieldMax
Inception DateMar 11, 2026
Dividend Yield1.58%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume8,366
30 Day Avg. Volume4,942
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
35.72Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering100
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DDDD Summary
YieldMax U.S. Stocks Target Double Distribution ETF (DDDD) is an income-focused fund built on Schwab U.S. Dividend Equity ETF (SCHD), which holds many strong, dividend-paying U.S. companies. Through SCHD, you get exposure to well-known names like Coca-Cola and PepsiCo, plus sectors such as health care, technology, and energy. DDDD then adds an options strategy on top to try to roughly double the cash payouts you’d normally get from SCHD, making it appealing for investors seeking higher income. However, this approach can limit how much you gain in strong markets and the share price can still go up and down with the market.
How much will it cost me?This ETF has an expense ratio of 1.01%, which means you’ll pay about $10.10 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and uses a more complex options strategy to try to boost income.
What would affect this ETF?This ETF could benefit if the U.S. economy stays stable, interest rates fall, and large, established dividend payers in sectors like health care, consumer staples, and energy remain profitable, since that supports both dividend payments and the options income strategy. On the downside, a sharp market rally could see the fund lag because its options approach can cap gains, while rising rates, tighter regulations, or sector-specific problems for key holdings like Texas Instruments, UnitedHealth, or Chevron could pressure both stock prices and the income it can generate.
DDDD Top 10 Holdings
This fund is really a one-ticket play on U.S. dividend stalwarts, with health care, consumer defensive names, and chipmakers setting the tone. Texas Instruments has been one of the main engines lately, with Qualcomm also adding juice despite a recent wobble. On the defensive side, UnitedHealth and Merck are steady anchors, while Coca-Cola and Procter & Gamble keep the income stream humming rather than racing ahead. Chevron and Verizon have been more mixed, occasionally losing steam, but the overall story is broad, U.S.-only dividend strength with an options twist on top.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Home Depot | 4.52% | $252.32K | $356.87B | -6.06% | 66 Neutral | |
| Merck & Company | 4.47% | $249.40K | $319.99B | 58.36% | 80 Outperform | |
| UnitedHealth | 4.46% | $248.84K | $386.29B | 35.84% | 72 Outperform | |
| Amgen | 4.37% | $243.95K | $201.93B | 23.94% | 77 Outperform | |
| Abbott Laboratories | 4.33% | $241.55K | $166.17B | -28.13% | 73 Outperform | |
| Procter & Gamble | 4.27% | $238.32K | $352.57B | -3.26% | 69 Neutral | |
| Coca-Cola | 4.23% | $235.76K | $362.01B | 19.66% | 75 Outperform | |
| PepsiCo | 4.00% | $223.25K | $197.12B | 7.36% | 78 Outperform | |
| Texas Instruments | 3.76% | $209.55K | $266.73B | 40.10% | 78 Outperform | |
| Verizon | 3.61% | $201.31K | $177.71B | -1.09% | 81 Outperform |
DDDD Technical Analysis
Positive
―
Price Trends
31.59
Positive
Market Momentum
0.02
Negative
58.67
Neutral
42.97
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DDDD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 31.71, equal to the 50-day MA of 31.59, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 58.67 is Neutral, neither overbought nor oversold. The STOCH value of 42.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DDDD.
DDDD Peer Comparison
Comparison Results
Performance Comparison
DDDD
YieldMax U.S. Stocks Target Double Distribution ETF
32.02
1.72
5.68%
FDIV
MarketDesk Focused U.S. Dividend ETF
―
―
―
PAYR
Federated Hermes Enhanced Income ETF
―
―
―
DIVY
Sound Equity Income ETF
―
―
―
VUS
Virtus US Dividend ETF
―
―
―
JHDV
John Hancock U.S. High Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents